We are live on ! Find out more
NBP icon

NovaBridge Biosciences American Depositary Shares

29 hedge funds and large institutions have $7.41M invested in NovaBridge Biosciences American Depositary Shares in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

45% more call options, than puts

Call options by funds: $16K | Put options by funds: $11K

4% more funds holding

Funds holding: 28 → 29 (+1)

0% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 5

3.58% less ownership

Funds ownership: 14.62% → 11.03% (-3.6%)

70% less capital inflows, than outflows

Capital inflows: $1.12M | Capital outflows: $3.67M

Holders
29
Holders Change
+1
Holders Change %
+3.57%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
5
Closed
3
Calls
$16​K
Puts
$11​K
Net Calls
+$5​K
Net Calls Change
+$17​K

NBP Hedge Fund Activity: Q1 2025 in Review

29 of the 7,493 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q1 2025, worth a combined $7.41M — down 27% from $10.1M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new NBP positions and 3 closed out — a net gain of 2 holders — while 5 added to existing stakes and 5 trimmed.

The largest buyer was Stonepine Capital Management, opening a new position worth an estimated $459K. The largest seller was Morgan Stanley, cutting an estimated $3.33M.

  • 29 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q1 2025, up from 28 in Q4 2024.
  • Funds reported $7.41M of NovaBridge Biosciences American Depositary Shares stock for Q1 2025, down 27% quarter-over-quarter.
  • 5 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q1 2025 and 3 closed out, a net change of +2 holders.
  • The largest NovaBridge Biosciences American Depositary Shares buyer in Q1 2025 was Stonepine Capital Management, an estimated $459K added.
  • The largest NovaBridge Biosciences American Depositary Shares seller in Q1 2025 was Morgan Stanley, an estimated $3.33M sold.

Based on aggregated 13F filings for Q1 2025.